Citation

Rajesh Gandhi, M.D., David O'Neill, M.D., Ronald J. Bosch, Ph.D., Ellen Chan, M.Sc., R. Pat Bucy, M.D., Ph.D., J. Shopis, Lynn Baglyos, M.S.N, Elizabeth Adams, M.D., Lawrence Fox, M.D., Ph.D., Lynette Purdue, Pharm.D., Ann Marshak, Teri Flynn, R.N., A.N.P., M.S.N, Reena Masih, M.A., Barbara Schock, M.S., Donna Mildvan, M.D., Sarah J. Schlesinger, M.D., Mary A Marovich, M.D., DTM&H, Nina Bhardwaj, M.D., Ph.D., Jeffrey M. Jacobson, M.D. A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 2009 Oct 09; 27(43):6088-94. PMID: 19450647; PMCID: PMC2820102.

Citation

Timothy J. Wilkin, M.D., M.P.H., Timothy J. Wilkin, M.D., M.P.H., John Ernest McKinnon, M.D., Greg DiRienzo, Ph.D., Katie Mollan, M.S., Courtney V. Fletcher, Pharm.D., David M. Margolis, M.D., Barbara Bastow, R.N., B.S.N., Gary D. Thal, M.D., William Chris Woodward, D.O., Catherine Godfrey, M.D., A. Wiegand, Frank Maldarelli, Sarah Palmer, Ph.D., John Coffin, M.D., John W. Mellors, M.D., Susan Swindells, M.B.B.S. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes. Journal of Infectious Diseases. 2009 Mar 15; 199(6):866-71. PMCID: PMC2756462.

Citation

Robert Gross, M.D., M.S.C.E., Camlin Tierney, Ph.D., Adriana Andrade, M.D., M.P.H., Christina M. Lalama, M.S., Susan L Rosenkranz, Ph.D., Susan H. Eshleman, M.D., PH.D., Timothy P. Flanigan, M.D., Jorge L. Santana, M.D., Nadim Salomon, M.D., Ronald B. Reisler, M.D., M.P.H., Ilene P. Wiggins, R.N., Evelyn Hogg, B.A., Charles Flexner, M.D., Donna Mildvan, M.D. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Archives of Internal Medicine. 2009 Jul 13; 169(13):1224-32. PMCID: PMC2771688.

Citation

Kristine Patterson, M.D., Susan Ellen Cohn, M.D., M.P.H., Jennifer Uyanik, Michael Hughes, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Joseph J. Eron, Jr., M.D. Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies. Clinical Infectious Diseases. 2009 Aug 01; 49(3):473-6. PMID: 19555288; PMCID: PMC2712125.

Citation

Allan R. Tenorio, M.D., John Spritzler, Sc.D., Jeff Martinson, Carolyne Gichinga, Richard B. Pollard, M.D., Michael M. Lederman, M.D., Robert C Kalayjian, M.D., Alan Landay, Ph.D. The effect of aging on T-regulatory cell frequency in HIV infection. Clinical Immunology and Immunopathology (Now Clin Immunol). 2009 Mar 01; 130(3):298-303. PMID: 19008157; PMCID: PMC2662473.

Citation

Jack T. Stapleton, M.D., Kathryn M. Chaloner, Ph.D., Jiameng Zhang, Ph.D., Donna Klinzman, B.A., I. E. Souza, Jinhua Xiang, Alan Landay, Ph.D., John L. Fahey, M.D., Richard B. Pollard, M.D., Ronald T. Mitsuyasu, M.D. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009 Mar 13; 23(5):605-610. PMCID: PMC2739595.

Citation

Dominic Chow, M.D., M.P.H., Huichao Chen, Ph.D., Marshall Jay Glesby, M.D., Ph.D., Anthony J. Busti, Pharm.D., B.P.S., Scott Souza, Pharm.D., Janet Andersen, Sc.D., Sharon Kohrs, R.N., B.S.N., Julia (Wei) Wu, M.S., Susan L. Koletar, M.D. Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients. AIDS. 2009 Oct 23; 23(16):2133-41. PMID: 19770624; PMCID: PMC2782438.

Citation

Todd T. Brown, M.D., Marlene Smurzynski, Ph.D., M.S.P.H., Kunling Wu, M.S., Ronald J. Bosch, Ph.D., Grace McComsey, M.D. Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort. Antiviral Therapy. 2009 Oct 05; 14(6):853-8. PMID: 19812448; PMCID: PMC2865258.

Citation

Paul Edward Sax, M.D., Camlin Tierney, Ph.D., Ann C. Collier, M.D., Margaret A. Fischl, M.D., Katie Mollan, M.S., Lynne Peeples, M.S., Catherine Godfrey, M.D., Nasreen Jahed, M.P.H., Laurie S. Myers, M.S., M.T. (A.S.C.P.), David Katzenstein, M.D., Awny Farajallah, M.D., James F. Rooney, M.D., Belinda Ha, Ph.D., William Chris Woodward, D.O., Susan L. Koletar, M.D., Victoria A. Johnson, M.D., P. Jan Geiseler, M.D., Eric S Daar, M.D. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. New England Journal of Medicine. 2009 Dec 03; 361(23):2230-40. PMID: 19952143; PMCID: PMC2800041.

Citation

Mark A. Jacobson, M.D., Dirk P. Dittmer, Ph.D., Elizabeth Sinclair, Ph.D., Jeffrey N. Martin, Steven G. Deeks, M.D., Peter W. Hunt, M.D., Edward S. Mocarski, Caroline Shiboski, D.D.S., M.P.H., Ph.D. Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. Public Library of Science One. 2009 Apr 17; 4(4):e5277. PMCID: PMC2667217.